Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PFIZER INC Director's Dealing 2021

Apr 2, 2021

29831_dirs_2021-04-02_9a6b16b8-7da9-4cce-9f77-a02d987de7c6.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2021-04-02

Reporting Person: Echevarria Joseph (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-04-02 Phantom Stock Units $ A 1188.0170 Acquired Common Stock (1188.0170) Direct

Footnotes

F1: Each unit represents one phantom share of common stock.

F2: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors.

F3: Price is the closing price of Pfizer common stock on April 1, 2021.